Clinical Trial Update: Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC) [Phase 1]

View source ↗

Summary

Phase 1 trial of chidamide plus celecoxib in advanced/metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Chidamide (chidamide)

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: TERMINATED